BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38415799)

  • 1. Comprehensive review of Bcl-2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small molecules.
    Iksen ; Witayateeraporn W; Hardianti B; Pongrakhananon V
    Phytother Res; 2024 May; 38(5):2249-2275. PubMed ID: 38415799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer.
    Sarkar A; Paul A; Banerjee T; Maji A; Saha S; Bishayee A; Maity TK
    Eur J Pharmacol; 2023 Apr; 944():175588. PubMed ID: 36791843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BH3 Mimetic Peptides: An Effective Strategy to Complement Anticancer Therapy.
    Saraswathy SD; Mirunalini A; Karthikeyan K; Premkumar K
    Curr Protein Pept Sci; 2023; 24(10):853-864. PubMed ID: 37608654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule redox modulators with anticancer activity: A comprehensive mechanistic update.
    Pal C
    Free Radic Biol Med; 2023 Nov; 209(Pt 2):211-227. PubMed ID: 37898387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 family isoforms in apoptosis and cancer.
    Warren CFA; Wong-Brown MW; Bowden NA
    Cell Death Dis; 2019 Feb; 10(3):177. PubMed ID: 30792387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer.
    Ngoi NYL; Choong C; Lee J; Bellot G; Wong ALA; Goh BC; Pervaiz S
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32131385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy.
    Qian S; Wei Z; Yang W; Huang J; Yang Y; Wang J
    Front Oncol; 2022; 12():985363. PubMed ID: 36313628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and apoptosis cascade: which is more prominent in neuronal death?
    Gupta R; Ambasta RK; Pravir Kumar
    Cell Mol Life Sci; 2021 Dec; 78(24):8001-8047. PubMed ID: 34741624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.
    Alam M; Ali S; Mohammad T; Hasan GM; Yadav DK; Hassan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Compounds from Cyanobacteria and their Implications in Apoptosis.
    Gupta A; Singh PR; Singh AP; Kumari N; Jaiswal J; Sahu N; Mishra S; Pathak J; Sinha RP
    Curr Protein Pept Sci; 2023; 24(10):805-819. PubMed ID: 37055887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides and non-peptidic molecules as probes of structure and function of Bcl-2 family proteins and modulators of apoptosis.
    Liu D; Huang Z
    Apoptosis; 2001 Dec; 6(6):453-62. PubMed ID: 11595835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation.
    Aniogo EC; George BPA; Abrahamse H
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33203053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.
    Yu L; Liu S
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):553-60. PubMed ID: 24012660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer and Apoptosis.
    Chaudhry GE; Akim AM; Sung YY; Muhammad TST
    Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.
    Renault TT; Elkholi R; Bharti A; Chipuk JE
    J Biol Chem; 2014 Sep; 289(38):26481-26491. PubMed ID: 25096574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.
    Hogg SJ; Newbold A; Vervoort SJ; Cluse LA; Martin BP; Gregory GP; Lefebure M; Vidacs E; Tothill RW; Bradner JE; Shortt J; Johnstone RW
    Mol Cancer Ther; 2016 Sep; 15(9):2030-41. PubMed ID: 27406984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-proteasome pathway-mediated regulation of the Bcl-2 family: effects and therapeutic approaches.
    Tang GLQ; Lai JXH; Pervaiz S
    Haematologica; 2024 Jan; 109(1):33-43. PubMed ID: 37584295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2.
    Pohl SÖ; Agostino M; Dharmarajan A; Pervaiz S
    Antioxid Redox Signal; 2018 Nov; 29(13):1215-1236. PubMed ID: 29304561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
    Koehler BC; Jassowicz A; Scherr AL; Lorenz S; Radhakrishnan P; Kautz N; Elssner C; Weiss J; Jaeger D; Schneider M; Schulze-Bergkamen H
    BMC Cancer; 2015 Nov; 15():919. PubMed ID: 26585594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New synthetic phenylquinazoline derivatives induce apoptosis by targeting the pro-survival members of the BCL-2 family.
    Eugin Simon S; Ahmed U; Saad SM; Anwar A; Khan KM; Tan EW; Tan KO
    Bioorg Med Chem Lett; 2022 Jul; 67():128731. PubMed ID: 35421577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.